The immunobiology of prostanoid receptor signaling in connecting innate and adaptive immunity

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Harizi, Hedi ^a  

^a UNIVERSITY OF MONASTIR   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE RECEPTOR; PROSTAGLANDIN E2; PROSTANOID; PROSTANOID RECEPTOR; PROSTAGLANDIN; PROSTAGLANDIN D2; PROSTAGLANDIN RECEPTOR; PROSTANOID D RECEPTOR 1, HUMAN;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; APOPTOSIS; CELL DIFFERENTIATION; CELL INTERACTION; CELL MIGRATION; CELL SURFACE; CELL SURVIVAL; CYTOKINE PRODUCTION; DENDRITIC CELL; EPIGENETICS; HUMAN; IMMUNOBIOLOGY; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; GENETICS; IMMUNOLOGY; INFLAMMATION; METABOLISM; NATURAL KILLER CELL;

ADAPTIVE IMMUNITY; DENDRITIC CELLS; DINOPROSTONE; HUMANS; IMMUNITY, INNATE; INFLAMMATION; KILLER CELLS, NATURAL; PROSTAGLANDIN D2; PROSTAGLANDINS; RECEPTORS, PROSTAGLANDIN; SIGNAL TRANSDUCTION;

EID: 84884278765     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/683405     Document Type: Review

References (101)

1. Harizi H., Corcuff J.-B., Gualde N., Arachidonic-acid-derived eicosanoids: roles in biology and immunopathology. Trends in Molecular Medicine 2008 14 10 461 469 2-s2.0-52949153587 10.1016/j.molmed.2008.08.005
2. Smyth E. M., Grosser T., Wang M., Yu Y., FitzGerald G. A., Prostanoids in health and disease. Journal of lipid research 2009 50 S423 S428 2-s2.0-66349102248 10.1194/jlr.R800094-JLR200
3. Ricciotti E., Fitzgerald G. A., Prostaglandins and inflammation. Arteriosclerosis, Thrombosis, and Vascular Biology 2011 31 5 986 1000 2-s2.0-79955586225 10.1161/ATVBAHA.110.207449
4. Walentynowicz K., Szefer M., Wojtal B., Terlecki P., Wrotek S., Kozak W., Role of prostaglandins in heme-induced fever. Journal of Physiology and Pharmacology 2006 57 8 73 82 2-s2.0-34047246119
5. Coussens L. M., Werb Z., Inflammation and cancer. Nature 2002 420 6917 860 867 2-s2.0-0037180757 10.1038/nature01322
6. 2 production by monocytes. British Journal of Cancer 1999 79 1 119 130 2-s2.0-0032889264 10.1038/sj.bjc.6690021
7. 2 and T-helper type 2 cytokine production in peripheral blood mononuclear cells. Annals of Surgical Oncology 2003 10 4 455 462 2-s2.0-0042161469 10.1245/ASO.2003.06.036
8. 2 by tumor cells in vivo. Cancer Research 2008 68 18 7520 7529 2-s2.0-54749107201 10.1158/0008-5472.CAN-08-1060
9. Funk C. D., Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 2001 294 5548 1871 1875 2-s2.0-0035976575 10.1126/science.294. 5548.1871
10. 2 among mouse strains: a possible mechanism to polarize Th2 type response in BALB/c mice. Journal of Immunology 2000 164 5 2386 2395 2-s2.0-0034163578
11. Aderem A. A., Cohen D. S., Wright S. D., Cohn Z. A., Bacterial lipopolysaccharides prime macrophages for enhanced release of arachidonic acid metabolites. Journal of Experimental Medicine 1986 164 1 165 179 2-s2.0-0022469232
12. Seibert K., Zhang Y., Leahy K., Hauser S., Masferrer J., Perkins W., Lee L., Isakson P., Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proceedings of the National Academy of Sciences of the United States of America 1994 91 25 12013 12017 2-s2.0-0027944075 10.1073/pnas.91.25.12013
13. 2 in human leukocytes by lipopolysaccharide. European Journal of Biochemistry 1994 223 3 743 749 2-s2.0-0027989836 10.1111/j.1432-1033.1994.tb19048.x
14. 2 synthase-2 by lipopolysaccharide in human polymorphonuclear leukocytes. European Journal of Haematology 1999 63 2 94 102 2-s2.0-0032772654
15. 2 enhances the production of endogenous IL-10, which down-regulates dendritic cell functions. Journal of Immunology 2002 168 5 2255 2263 2-s2.0-0036498542
16. Harizi H., Gualde N., The impact of eicosanoids on the crosstalk between innate and adaptive immunity: the key roles of dendritic cells. Tissue Antigens 2005 65 6 507 514 2-s2.0-20144370418 10.1111/j.1399-0039.2005.00394.x
17. 2 that contributes to the immunomodulation induced by antigen-presenting cells. Cellular Immunology 2001 209 1 19 28 2-s2.0-0035836413 10.1006/cimm.2001.1785
18. 2 receptor via p38 and ERK MAPKs. Immunology and Cell Biology 2011 89 2 275 282 2-s2.0-79951959153 10.1038/icb.2010.94
19. 2 production in human lung fibroblasts. Journal of Immunology 1998 160 3 1053 1057 2-s2.0-0031993721
20. Dongari-Bagtzoglou A. I., Thienel U., Yellin M. J., CD40 ligation triggers COX-2 expression in endothelial cells: evidence that CD40-mediated IL-6 synthesis is COX-2-dependent. Inflammation Research 2003 52 1 18 25 2-s2.0-0037285989 10.1007/s000110300009
21. Inoue Y., Otsuka T., Niiro H., Nagano S., Arinobu Y., Ogami E., Akahoshi M., Miyake K., Ninomiya I., Shimizu S., Nakashima H., Harada M., Novel regulatory mechanisms of CD40-induced prostanoid synthesis by IL-4 and IL-10 in human monocytes. Journal of Immunology 2004 172 4 2147 2154 2-s2.0-10744226270
22. Hida T., Yatabe Y., Achiwa H., Muramatsu H., Kozaki K.-I., Nakamura S., Ogawa M., Mitsudomi T., Sugiura T., Takahashi T., Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Research 1998 58 17 3761 3764 2-s2.0-0032170955
23. Gately S., The contributions of cyclooxygenase-2 to tumor angiogenesis. Cancer and Metastasis Reviews 2000 19 1-2 19 27 2-s2.0-0034530889 10.1023/A:1026575610124
24. Harris S. G., Padilla J., Koumas L., Ray D., Phipps R. P., Prostaglandins as modulators of immunity. Trends in Immunology 2002 23 3 144 150 2-s2.0-0036499224 10.1016/S1471-4906(01)02154-8
25. 2 at new glance: novel insights in functional diversity offer therapeutic chances. International Journal of Biochemistry and Cell Biology 2010 42 2 198 201 2-s2.0-73749088151 10.1016/j.biocel.2009.09.015
26. 2 synthases. Biochemical Journal 2001 359 3 507 516 2-s2.0-0035504857 10.1042/0264-6021: 3590507
27. 2 inhibits the production of interleukin-12 in murine dendritic cells through multiple signaling pathways. European Journal of Immunology 2003 33 4 889 898 2-s2.0-0038744603 10.1002/eji.200323330
28. Hirata T., Narumiya S., Prostanoids as regulators of innate and adaptive immunity. Advances in Immunology 2012 116 143 174
29. Hata A. N., Breyer R. M., Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation. Pharmacology and Therapeutics 2004 103 2 147 166 2-s2.0-4444262310 10.1016/j.pharmthera.2004. 06.003
30. 2 by human osteoblasts and modulation of osteoprotegerin, RANKL, and cellular migration by DP and CRTH2 receptors. Journal of Bone and Mineral Research 2005 20 4 672 681 2-s2.0-15344348453 10.1359/JBMR.041211
31. Luster A. D., Tager A. M., T-cell trafficking in asthma: lipid mediators grease the way. Nature Reviews Immunology 2004 4 9 711 724 2-s2.0-4544296118 10.1038/nri1438
32. Chensue S. W., Kunkel S. L., Arachidonic acid metabolism and macrophage activation. Clinics in Laboratory Medicine 1983 3 4 677 694 2-s2.0-0021088719
33. Tilley S. L., Coffman T. M., Koller B. H., Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. Journal of Clinical Investigation 2001 108 1 15 23 2-s2.0-0034943516 10.1172/JCI200113416
34. Gualde N., Harizi H., Prostanoids and their receptors that modulate dendritic cell-mediated immunity. Immunology and Cell Biology 2004 82 4 353 360 2-s2.0-4344649438 10.1111/j.0818-9641.2004.01251.x
35. Whittaker D. S., Bahjat K. S., Moldawer L. L., Clare-Salzler M. J., Autoregulation of human monocyte-derived dendritic cell maturation and IL-12 production by cyclooxygenase-2-mediated prostanoid production. Journal of Immunology 2000 165 8 4298 4304 2-s2.0-0034667890
36. 2 Immunology and Cell Biology 2004 82 1 47 54 2-s2.0-1642296384 10.1111/j.1440-1711.2004.01213.x
37. 2 in the skin. American Journal of Pathology 2010 176 1 227 237 2-s2.0-73949094152 10.2353/ajpath.2010. 090111
38. 2 metabolite generated during inflammatory processes. Journal of Biological Chemistry 2002 277 12 10459 10466 2-s2.0-0037155868 10.1074/jbc.M110314200
39. Phipps R. P., Stein S. H., Roper R. L., A new view of prostaglandin E regulation of the immune response. Immunology Today 1991 12 10 349 352 2-s2.0-0025744448
40. 2-dependent mechanism. Journal of Immunology 2006 177 1 246 254 2-s2.0-33745311263
41. 2 Journal of Leukocyte Biology 1984 35 3 291 301 2-s2.0-0021257348
42. 4 receptor subtypes. Journal of Leukocyte Biology 2003 73 6 756 763 2-s2.0-0037666202 10.1189/jlb.1002483
43. 4 subtypes regulate activation and differentiation of mouse B lymphocytes to IgE-secreting cells. Proceedings of the National Academy of Sciences of the United States of America 1996 93 20 10978 10983 2-s2.0-0029662157 10.1073/pnas.93.20.10978
44. Rocca B., Spain L. M., Puré E., Langenbach R., Patrono C., FitzGerald G. A., Distinct roles of prostaglandin H synthases 1 and 2 in T-cell development. Journal of Clinical Investigation 1999 103 10 1469 1477 2-s2.0-0032696786
45. Narumiya S., FitzGerald G. A., Genetic and pharmacological analysis of prostanoid receptor function. Journal of Clinical Investigation 2001 108 1 25 30 2-s2.0-0034931501 10.1172/JCI200113455
46. Coleman R. A., Smith W. L., Narumiya S., VIII. International union of pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacological Reviews 1994 46 2 205 229 2-s2.0-0028183018
47. 2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. Journal of Experimental Medicine 2001 193 2 255 261 2-s2.0-0035862329 10.1084/jem.193.2.255
48. 2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor. Blood 2001 98 6 1942 1948 2-s2.0-0035883174 10.1182/blood.V98.6.1942
49. Nagata K., Hirai H., Tanaka K., Ogawa K., Aso T., Sugamura K., Nakamura M., Takano S., CRTH2, an orphan receptor of T-helper-2-cells, is expressed on basophils and eosinophils and responds to mast cell-derived factor(s). FEBS Letters 1999 459 2 195 199 2-s2.0-0032829392 10.1016/S0014-5793(99)01251-X
50. 2 receptors. Proceeding of the National Academy of Science USA 1998 22 95 15792 15797
51. 2 and the ligation of PPAR γ Journal of Clinical Investigation 2003 112 6 945 955 2-s2.0-0142186679 10.1172/JCI200318012
52. 2 cause potent neuroprotection after experimental stroke through noncompletely overlapping mechanisms. Journal of Cerebral Blood Flow and Metabolism 2006 26 2 218 229 2-s2.0-31444445868 10.1038/sj.jcbfm.9600182
53. 2 inhibits translation through inactivation of eIF4A. EMBO Journal 2007 26 24 5020 5032 2-s2.0-37149023303 10.1038/sj.emboj.7601920
54. Juzan M., Hostein I., Gualde N., Role of thymus-eicosanoids in the immune response. Prostaglandins Leukotrienes and Essential Fatty Acids 1992 46 4 247 255 2-s2.0-0026726641 10.1016/0952-3278(92)90030-M
55. Gualde N., Harizi H., Prostanoids and their receptors that modulate dendritic cell-mediated immunity. Immunology and Cell Biology 2004 82 4 353 360 2-s2.0-4344649438 10.1111/j.0818-9641.2004.01251.x
56. 2 receptor. Journal of Clinical Investigation 2003 111 5 727 735 2-s2.0-0037332595 10.1172/JCI200316492
57. 2 receptors DP1 and CRTH2 as an approach to treat allergic diseases. Nature Reviews Drug Discovery 2007 6 4 313 325 2-s2.0-33947726053 10.1038/nrD2266
58. 2 receptors DP1 and CRTH2 in promoting allergic responses. British Journal of Pharmacology 2008 153 1 S191 S199 2-s2.0-40349108550 10.1038/sj.bjp.0707488
59. 2 is an early anti-inflammatory signal in experimental colitis. American Journal of Physiology. Gastrointestinal and Liver Physiology 2000 279 1 G238 G244 2-s2.0-0033853737
60. Ianaro A., Ialenti A., Maffia P., Pisano B., Di Rosa M., Role of cyclopentenone prostaglandins in rat carrageenin pleurisy. FEBS Letters 2001 508 1 61 66 2-s2.0-0035834392 10.1016/S0014-5793(01)03035-6
61. Arimura A., Yasui K., Kishino J., Asanuma F., Hasegawa H., Kakudo S., Ohtani M., Arita H., Prevention of allergic inflammation by a novel prostaglandin receptor antagonist, S-5751. Journal of Pharmacology and Experimental Therapeutics 2001 298 2 411 419 2-s2.0-0034922462
62. Banchereau J., Steinman R. M., Dendritic cells and the control of immunity. Nature 1998 392 6673 245 252 2-s2.0-0032546352 10.1038/32588
63. Shortman K., Naik S. H., Steady-state and inflammatory dendritic-cell development. Nature Reviews Immunology 2007 7 1 19 30 2-s2.0-33845898737 10.1038/nri1996
64. 2 in immunity and immunopathology. Cellular and Molecular Immunology 2013 10 3 213 221
65. 4 Journal of Immunotherapy 2012 35 2 179 188 2-s2.0-84856888800 10.1097/CJI.0b013e318247a5e9
66. Vitale M., Chiesa M. D., Carlomagno S., Romagnani C., Thiel A., Moretta L., Moretta A., The small subset of CD56brightCD16- natural killer cells is selectively responsible for both cell proliferation and interferon- γ production upon interaction with dendritic cells. European Journal of Immunology 2004 34 6 1715 1722 2-s2.0-3242706150 10.1002/eji.200425100
67. Gerosa F., Baldani-Guerra B., Nisii C., Marchesini V., Carra G., Trinchieri G., Reciprocal activating interaction between natural killer cells and dendritic cells. Journal of Experimental Medicine 2002 195 3 327 333 2-s2.0-0037017381 10.1084/jem.20010938
68. Fernandez N. C., Lozier A., Flament C., Ricciardi-Castagnoli P., Bellet D., Suter M., Perricaudet M., Tursz T., Maraskovsky E., Zitvogel L., Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nature Medicine 1999 5 4 405 411 2-s2.0-0032903599 10.1038/7403
69. Degli-Esposti M. A., Smyth M. J., Close encounters of different kinds: dendritic cells and NK cells take centre stage. Nature Reviews Immunology 2005 5 2 112 124 2-s2.0-13444311714 10.1038/nri1549
70. 2 is a potent regulator of interleukin-12- and interleukin-18-induced natural killer cell interferon- γ synthesis. Immunology 2004 111 3 298 305 2-s2.0-1642290687 10.1111/j.1365-2567.2004.01810.x
71. 2 inhibits natural killer and γ δ T cell cytotoxicity triggered by NKR and TCR through a cAMP-mediated PKA type I-dependent signaling. Biochemical Pharmacology 2010 80 6 838 845 2-s2.0-77954761322 10.1016/j.bcp.2010.05.002
72. 4 Cancer Immunology, Immunotherapy 2011 60 11 1577 1586 2-s2.0-82355182118 10.1007/s00262-011-1064-9
73. Gustafsson K., Ingelsten M., Bergqvist L., Nyström J., Andersson B., Karlsson-Parra A., Recruitment and activation of natural killer cells in vitro by a human dendritic cell vaccine. Cancer Research 2008 68 14 5965 5971 2-s2.0-48649092619 10.1158/0008-5472.CAN-07-6494
74. Enk A. H., Angeloni V. L., Udey M. C., Katz S. I., Inhibition of Langerhans cell antigen-presenting function by IL-10: a role for IL-10 in induction of tolerance. Journal of Immunology 1993 151 5 2390 2398 2-s2.0-0027320133
75. Enk A. H., Jonuleit H., Saloga J., Knop J., Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma. International Journal of Cancer 1997 4 73 309 316
76. Mandaric S., Walton S. M., Rülicke T. R., Richter K., Girard-Madoux M. J., Clausen B. E., Zurunic A., Kamanaka M., Flavell R. A., Jonjic S., Oxenius A., IL-10 suppression of NK/DC crosstalk leads to poor priming of MCMV-specific CD4 T cells and prolonged MCMV persistence. PLoS Pathogenes 2012 8 8 10.1371/journal.ppat.1002846 1002846
77. Troy A. J., Summers K. L., Davidson P. J. T., Atkinson C. H., Hart D. N. J., Minimal recruitment and activation of dendritic cells within renal cell carcinoma. Clinical Cancer Research 1998 4 3 585 593 2-s2.0-0031924545
78. 2 DP, and IP but not EP1, EP3, and FP prostanoid receptors are involved. International Immunopharmacology 2003 3 6 865 878 2-s2.0-0038392646 10.1016/S1567-5769(03)00072-9
79. 2 that regulate cellular immune responses in the mouse. Journal of Clinical Investigation 2001 108 8 1229 1235 2-s2.0-0034783581 10.1172/JCI200113640
80. 3 receptors attenuates Flt3L-dependent dendritic cell development from hematopoietic progenitor cells. Blood 2012 119 7 1671 1682 2-s2.0-84857497320 10.1182/blood-2011-03-342428
81. Urade Y., Hayaishi O., Prostaglandin D synthase: structure and function. Vitamins and Hormones 2000 58 89 120 2-s2.0-0033627825
82. 2 as a mediator of allergic asthma. Science 2000 287 5460 2013 2017 2-s2.0-0034677595 10.1126/science.287.5460.2013
83. Robinson C., Hardy C. C., Holgate S. T., Pulmonary synthesis, release, and metabolism of prostaglandins. Journal of Allergy and Clinical Immunology 1985 76 265 271 2-s2.0-0022357492
84. 2 into human airways during acute antigen challenge. The New England Journal of Medicine 1986 315 13 800 804 2-s2.0-0022557575
85. 2 and its metabolites in leukocyte function. Journal of Leukocyte Biology 2007 81 2 372 382 2-s2.0-33846687384 10.1189/jlb.0706424
86. 2 affects the maturation of human monocyte-derived dendritic cells: consequence on the polarization of naive Th cells. Journal of Immunology 2003 170 10 4943 4952 2-s2.0-0037988825
87. Jira M., Antosova E., Vondra V., Strejcek J., Mazakova H., Prazakova J., Natural killer and interleukin-2 induced cytotoxicity in asthmatics. I. Effect of acute antigen-specific challenge. Allergy 1988 43 4 294 298 2-s2.0-0023925136
88. 2 suppresses human NK cell function via signaling through D prostanoid receptor. Journal of Immunology 2007 179 5 2766 2773 2-s2.0-38049163745
89. 2 polarized immune responses in vivo. Immunobiology 2006 211 6-8 463 472 2-s2.0-33747356525 10.1016/j.imbio.2006.05.020
90. 4 signaling initiates skin immune responses by promoting migration and maturation of Langerhans cells. Nature Medicine 2003 9 6 744 749 2-s2.0-0038240422 10.1038/nm872
91. Steinbrink K., Wölfl M., Jonuleit H., Knop J., Enk A. H., Induction of tolerance by IL-10-treated dendritic cells. Journal of Immunology 1997 159 10 4772 4780 2-s2.0-0031573204
92. Braun D., Longman R. S., Albert M. L., A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation. Blood 2005 106 7 2375 2381 2-s2.0-27144476792 10.1182/blood-2005-03-0979
93. Mellor A. L., Munn D. H., IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nature Reviews Immunology 2004 4 10 762 774 2-s2.0-5044220930 10.1038/nri1457
94. 2 differentially modulates cytokine secretion profiles of human T helper lymphocytes. Journal of Immunology 1993 150 12 5321 5329 2-s2.0-0027336504
95. 2 production is likely antigen-presenting cells. Localization of glutathione-requiring prostaglandin D synthetase in histiocytes, dendritic, and Kupffer cells in various rat tissues. Journal of Immunology 1989 143 9 2982 2989 2-s2.0-0024432264
96. 2 by human helper T cell subsets. Journal of Immunology 2000 164 5 2277 2280 2-s2.0-0034161713
97. Bilyk N., Holt P. G., Cytokine modulation of the immunosuppressive phenotype of pulmonary alveolar macrophage populations. Immunology 1995 86 2 231 237 2-s2.0-0028853773
98. Cebola I., Peinado M. A., Epigenetic deregulation of the COX pathway in cancer. Progress in Lipid Research 2012 51 4 301 313
99. Gray S. G., Al-Sarraf N., Baird A.-M., Cathcart M.-C., McGovern E., O'Byrne K. J., Regulation of EP receptors in non-small cell lung cancer by epigenetic modifications. European Journal of Cancer 2009 45 17 3087 3097 2-s2.0-70449111359 10.1016/j.ejca.2009.09.006
100. Cosío B. G., Mann B., Ito K., Jazrawi E., Barnes P. J., Chung K. F., Adcock I. M., Histone acetylase and deacetylase activity in alveolar macrophages and blood mononocytes in asthma. American Journal of Respiratory and Critical Care Medicine 2004 170 2 141 147 2-s2.0-3142676314
101. Sugino Y., Misawa A., Inoue J., Kitagawa M., Hosoi H., Sugimoto T., Imoto I., Inazawa J., Epigenetic silencing of prostaglandin E receptor 2 (PTGER2) is associated with progression of neuroblastomas. Oncogene 2007 26 53 7401 7413 2-s2.0-36349009317 10.1038/sj.onc.1210550